Related Experiment Video

Updated: Jun 20, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

Identification and management of familial hypercholesterolaemia: what does it mean to primary care?

Nadeem Qureshi1, Steve E Humphries, Mary Seed

  • 1Graduate Medical School, University of Nottingham, City Hospital, Derby. nadeem.qureshi@nottingham.ac.uk

The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|September 22, 2009
PubMed

Insights

Familial hypercholesterolaemia, a common genetic disorder causing high cholesterol, is often missed in primary care. Early identification and specialist referral are crucial for managing this condition and preventing heart disease.

Area of Science:

  • Genetics
  • Cardiology
  • Primary Care Medicine

Background:

  • Familial hypercholesterolaemia (FH) is a prevalent autosomal dominant genetic disorder.
  • It leads to significantly elevated serum cholesterol levels from early life.
  • Despite its prevalence (1 in 500), less than 15% of affected individuals are diagnosed and managed in lipid clinics.

Purpose of the Study:

  • To highlight the underdiagnosis of FH in general practice.
  • To emphasize the importance of primary care in identifying FH cases.
  • To discuss the role of GPs in managing FH based on new guidelines.

Main Methods:

  • Review of the prevalence and diagnostic challenges of FH.
  • Analysis of the National Institute for Health and Clinical Excellence (NICE) guideline for FH.
  • Discussion of primary care's role in case finding and patient support.

Main Results:

  • FH is frequently unrecognized in primary care settings.
  • Systematic and opportunistic case finding can improve diagnosis rates.
  • GPs play a vital role in reinforcing specialist advice and facilitating cascade screening.

Conclusions:

  • Improved identification of FH in primary care is essential.
  • Primary care physicians are key to bridging the gap between diagnosis and specialist care.
  • Effective management requires collaboration between GPs and lipid specialists for cascade screening.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Primary Healthcare Services01:30

Primary Healthcare Services

Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...